-
Determinants of Unregistered Medicines Importation in Saudi Arabia: A National Regulatory Analysis
Aug 20, 2026, 15:06 PM -
From Evidence to Elimination: A Decade of HEOR informing Taiwan's National Hepatitis C DAA Reimbursement Policy
Aug 20, 2026, 15:06 PM -
Regulatory Assessment of Emergency and Critical Care Services in Dubai: Using Evidence to Drive System-Level Reform
Aug 20, 2026, 15:06 PM -
Implementing Value-Based Care in Maxillofacial Procedures: A Pilot Study on Protocol-Driven Decision Making, Economic Outcomes, and Patient Satisfaction in a Brazilian Payer System
Aug 20, 2026, 15:06 PM -
Scan-2030: building a decision-ready health technology assessment ecosystem in hong kong for sustainable access to innovative medicines
Aug 20, 2026, 15:06 PM -
The Impact of HTA on Vitamin D Testing in Switzerland
Aug 20, 2026, 15:06 PM -
EXAMINING HOW HEALTH EQUITY IS CONSIDERED IN HEALTH TECHNOLOGY ASSESSMENT: AN ANALYSIS OF DOCUMENTS FROM FOUR BODIES
Aug 20, 2026, 13:29 PM -
TERRITORIAL INEQUALITIES OF PRACTICING PHYSICIANS IN HUNGARY AND THE DACH COUNTRIES IN 2024: A GINI AND THEIL INDEX-BASED ANALYSIS
Aug 20, 2026, 13:29 PM -
HOW MANY PICOS CAN ONE ASSESSMENT CARRY? SCOPE AND FEASIBILITY IN EU JOINT CLINICAL ASSESSMENT
Aug 20, 2026, 13:29 PM -
CRITICAL ANALYSIS OF THE HISTORY AND IMPACT OF COST-EFFECTIVENESS THRESHOLDS: LESSONS AND INSIGHTS FOR DECISION-MAKERS
Aug 20, 2026, 13:29 PM -
WHAT PREDICTIVE ACCURACY IS REQUIRED FOR AN ARTIFICIAL INTELLIGENCE TOOL TO BE COST-EFFECTIVE IN PREDICTING DIALYSIS NEED AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE?
Aug 20, 2026, 13:29 PM -
METHODOLOGICAL FIT BETWEEN THE EU JOINT CLINICAL ASSESSMENT AND EVIDENCE GENERATION FOR ADVANCED THERAPY AND ORPHAN MEDICINES
Aug 20, 2026, 13:29 PM -
AI DELPHI: A FRAMEWORK FOR BENCHMARKING THE WRITING QUALITY OF LARGE LANGUAGE MODELS (LLMS) IN HEALTH ECONOMICS AND OUTCOMES RESEARCH (HEOR) SETTINGS, A CANADIAN PROOF-OF-CONCEPT
Aug 20, 2026, 13:29 PM -
EVIDENCE GAPS AND STRATEGIC LESSONS FROM THE TOVORAFENIB CASE - A CRITICAL APPRAISAL OF FIRST EU JCA REPORT
Aug 20, 2026, 13:29 PM -
FROM PRICE COMPRESSION TO LIFECYCLE VALUE MANAGEMENT: IMPLICATIONS OF CHINA'S 2026 DRUG PRICING REFORM
Aug 20, 2026, 13:29 PM -
EXPLORING THE RELATIONSHIP BETWEEN SURROGATE ENDPOINTS AND CLINICAL OUTCOMES IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD): A SYSTEMATIC LITERATURE REVIEW
Aug 20, 2026, 13:29 PM -
DOES THE EQ-HWB-9 CAPTURE CAREGIVER BURDEN? EVIDENCE FROM FAMILY CAREGIVERS OF PEOPLE WITH SCHIZOPHRENIA IN CHINA
Aug 20, 2026, 13:29 PM -
PHARMACIST-LED VACCINATION IN FRANCE: DRIVERS OF ACCEPTABILITY ACROSS HEALTHCARE USERS, GENERAL PRACTITIONERS, AND PHARMACISTS
Aug 20, 2026, 13:29 PM -
WHEN THE TAIL WAGS THE DOG III: A PERSIST-VERSUS-FADE EXTRAPOLATION CHOICE AND THE SURVIVAL RATIO SHIFT (RASOLUTE302)
Aug 20, 2026, 13:29 PM -
PREFERENCES FOR TARGETED THERAPY ATTRIBUTES AMONG CHINESE PATIENTS WITH ALK-POSITIVE ADVANCED NON-SMALL CELL LUNG CANCER: A DISCRETE CHOICE EXPERIMENT
Aug 20, 2026, 13:29 PM
